Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

被引：0

作者：

Daniel Stoessel

Cameron J. Nowell

Amy J. Jones

Lori Ferrins

Katherine M. Ellis

Jennifer Riley

Raphael Rahmani

Kevin D. Read

Malcolm J. McConville

Vicky M. Avery

Jonathan B. Baell

Darren J. Creek

机构：

[1] Monash University,Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences

[2] Beuth University of Applied Sciences,Department of Biotechnology

[3] Monash University,Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences

[4] Griffith University,Discovery Biology, Eskitis Institute for Drug Discovery

[5] Monash University,Department of Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences

[6] University of Dundee,Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences

[7] University of Melbourne,Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute

来源：

Metabolomics | 2016年 / 12卷

关键词：

Human African trypanosomiasis; Metabolomics; Lipidomics; Sphingolipid metabolism;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 2 条